Volume 18, Number 3—March 2012
Research
Using Genotyping and Geospatial Scanning to Estimate Recent Mycobacterium tuberculosis Transmission, United States
Table 1
Variable | No. (%) clustered† | Total no. available | Crude OR (99% CI) | Adjusted OR (99% CI)‡ |
---|---|---|---|---|
Sex, n = 36,852 | ||||
M | 5,634 (66.3) | 23,136 | 1.2 (1.1–1.3) | 1.1 (1.0–1.2) |
F | 2,862 (33.7) | 13,716 | ||
Age group, y, n = 36,860 | ||||
0–4 | 206 (02.4) | 395 | 3.5 (2.7–4.6) | 3.1 (1.4–6.8) |
5–14 | 99 (01.2) | 333 | 1.4 (1.0–1.9) | 1.2 (0.8–1.9) |
15–24 | 1,131 (13.3) | 4,488 | 1.1 (1.0–1.2) | 1.1 (1.0–1.3) |
25–44 | 2,975 (35.0) | 12,688 | Referent | |
45–64 | 3,025 (35.6) | 11,247 | 1.0 (1.1–1.3) | 1.0 (0.9–1.0) |
>65 | 1,063 (12.5) | 7,709 | 0.5 (0.5–0.6) | 0.5 (0.4–0.6) |
Race/ethnicity, n = 36,761 | ||||
American Indian/Alaska Native | 111 (01.3) | 498 | 1.4 (0.9–1.5) | 0.8 (0.6–1.2) |
Asian, non-Hispanic | 1,496 (17.6) | 9,922 | 0.7 (0.6–0.8) | 1.5 (1.3–1.8) |
Black, non-Hispanic | 3,368 (39.7) | 9,471 | 2.2 (2.0–2.4) | 2.4 (2.2–2.7) |
Hispanic/Latino | 2,165 (25.5) | 10,238 | 1.1 (1.0–1.2) | 1.7 (1.5–2.0) |
Native Hawaiian/Pacific Islander | 59 (0.7) | 190 | 1.8 (1.2–2.7) | 2.6 (1.5–4.4) |
White, non-Hispanic | 1,272 (15.0) | 6,335 | Referent | § |
Other | 16 (0.2) | 107 | 0.7 (0.3–1.4) | 0.9 (0.4–2.2) |
Country of birth, n = 36,745 | ||||
United States | 4,871 (57.4) | 14,594 | 2.6 (2.4–2.7) | 2.4 (2.1–2.7) |
Non–US-born | 3,611 (42.6) | 22,151 | ||
In US <2 y | 1,100 (30.5) | 7,675 | Referent | ** |
In US 2–5 y | 531 (14.7) | 3,326 | 1.1 (1.0–1.3) | |
In US >5 y | 1,980 (54.8) | 11,150 | 1.3 (1.2–1.4) | |
Homelessness within past 12 mo, n = 36,558 | ||||
Yes | 946 (11.2) | 2,361 | 2.4 (2.1–2.7) | 1.4 (1.2–1.6) |
No | 7,488 (88.8) | 34,197 | ||
Substance abuse within past 12 mo, n = 36,860 | ||||
Yes | 2,415 (28.4) | 6,623 | 2.3 (2.1–2.5) | 1.4 (1.3–1.7) |
No | 6,082 (71.6) | 30,237 | ||
Residence at correctional facility at time of diagnosis, n = 36,815 | ||||
Yes | 369 (04.3) | 1,400 | 1.2 (1.0–1.4) | 0.8 (0.7–1.0) |
No | 8,121 (95.7) | 35,415 | ||
Residence at a long-term care facility at time of diagnosis, n = 36,801 | ||||
Yes | 180 (02.1) | 800 | 1.0 (0.8–1.2) | NS |
No | 8,304 (97.9) | 36,001 | ||
Reported HIV status, n = 36,860 | ||||
Positive | 741 (08.7) | 2,290 | 1.7 (1.5–1.9) | 1.1 (1.0–1.3) |
Not positive | 7,756 (91.3) | 34,570 | ||
Clinical presentation of TB, n = 36,779 | ||||
Pulmonary only | 6,653 (78.4) | 27,083 | 1.6 (1.5–1.8) | 1.2 (1.0–1.4) |
Extrapulmonary only | 992 (11.7) | 5,973 | Referent | |
Pulmonary and extrapulmonary | 841 (09.9) | 3,723 | 1.5 (1.3–1.7) | 1.0 (0.8–1.3) |
Sputum smear positivity, n = 31,625 | ||||
Yes | 4,640 (61.5) | 17,934 | 1.3 (1.2, 1.4) | 1.1 (1.0–1.2) |
No | 2,903 (38.5) | 13,691 | ||
Cavitary chest radiograph, n = 31,382 | ||||
Yes | 2,782 (36.8) | 10,411 | 1.2 (1.2–1.3) | 1.0 (0.9–1.1) |
No | 4,771 (63.2) | 20,971 | ||
Previous TB diagnosis, n = 36,544 | ||||
Yes | 426 (05.0) | 1,680 | 1.1 (1.0–1.3) | NS |
No | 8,010 (95.0) | 34,864 | ||
Mycobacterium tuberculosis or other species spoligotype-based lineage, n = 36,458 | ||||
East African Indian | 197 (02.3) | 1,582 | Referent | |
East Asian | 1,259 (14.9) | 4,924 | 2.4 (1.9–3.0) | 1.9 (1.5–2.6) |
Euro-American | 5,857 (69.2) | 23,441 | 2.3 (1.9–2.8) | 1.5 (1.2–2.0) |
Indo-Oceanic | 1,000 (11.8) | 5,760 | 1.5 (1.2–1.8) | 1.7 (1.3–2.3) |
M. africanum | 25 (0.3) | 179 | 1.1 (0.6–2.0) | 0.8 (0.4–1.7) |
M. bovis | 127 (01.5) | 572 | 2.0 (1.4–2.8) | 2.0 (1.3–3.2) |
*n values indicate number of persons for whom information in category was available. TB, tuberculosis; OR, odds ratio; NS, not significant. Boldface indicates significance at α = 0.01.
†Genotype clustering: >2 cases with identical spoligotype and 12-loci mycobacterial interspersed repetitive unit–variable-number tandem repeat genotypes occurring within a geospatially concentrated area identified by SaTScan (20). Cases must have clustered at least once in 1 of 3 consecutive, overlapping years (scan A, 2005–2007; scan B, 2006–2008; scan C, 2007–2009) (scan windows spatially limited to 50 km).
‡Final model, n = 31,382.
§Not included in the model to include both US-born and non–US-born case-patients.
Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.